Pharming Group N.V. (PHAR) Receivables - Other (2019 - 2024)

Pharming (PHAR) has disclosed Receivables - Other for 6 consecutive years, with $1.6 million as the latest value for Q4 2024.

  • For the quarter ending Q4 2024, Receivables - Other fell 25.59% year-over-year to $1.6 million, compared with a TTM value of $1.6 million through Dec 2024, down 25.59%, and an annual FY2024 reading of $1.6 million, down 25.59% over the prior year.
  • Receivables - Other was $1.6 million for Q4 2024 at Pharming, down from $2.1 million in the prior quarter.
  • Across five years, Receivables - Other topped out at $2.4 million in Q4 2021 and bottomed at $1.1 million in Q4 2022.
  • Average Receivables - Other over 5 years is $1.9 million, with a median of $2.1 million recorded in 2023.
  • The sharpest move saw Receivables - Other soared 161.89% in 2020, then plummeted 52.73% in 2022.
  • Year by year, Receivables - Other stood at $2.2 million in 2020, then increased by 5.59% to $2.4 million in 2021, then tumbled by 52.73% to $1.1 million in 2022, then surged by 92.03% to $2.1 million in 2023, then fell by 25.59% to $1.6 million in 2024.
  • Business Quant data shows Receivables - Other for PHAR at $1.6 million in Q4 2024, $2.1 million in Q4 2023, and $1.1 million in Q4 2022.